Tag Archives: pharmaceutical

Recent and upcoming investment in Mexico

Information collected from media reports over the last month:

  • Pharmaceutical: Mexican drug maker Chinoin invested US$12 million to boost production capacity at its plant in the central state of Aguascalientes, the company reported. Upgrades included acquisition of latest-generation laboratory testing equipment and construction of a new specialized building for the facility’s microbiology laboratory. (Reforma, July 28, 2017)
  • Automotive: U.S. auto maker Ford reported plans to invest approximately US$56 million to remodel its network of sales distributorships in Mexico. Upgrades for the 127 sales locations include WiFi, community centers and areas for viewing new models of sports cars. (El Financiero, July 28, 2017)
  • Wind power: Danish wind turbine maker Vestas, in conjunction with U.S. turbine blade producer TPI Composites, announced plans to construct a blade manufacturing plant in the northeastern state of Tamaulipas. The amount of investment was not specified for the plant, which is expected to produce blades for the V136 model turbine. (Reforma, July 20, 2017)
  • Automotive: German electronics and engineering multinational Bosch plans to open a new plant this year in the central state of Querétaro, the company reported. The US$80 million facility will produce automotive steering columns for regional OEMs such as Volkswagen, General Motors, Mazda, Honda and Toyota. (El Financiero, July 11, 2017)
  • Fuel storage: IEnova, the Mexican subsidiary of U.S. natural gas utility Sempra Energy, was awarded a concession to construct a fuel storage facility in the Gulf port city of Veracruz. The US$115 million site is planned to handle gasoline, diesel and aviation fuel. (El Financiero, July 13, 2017) Continue reading Recent and upcoming investment in Mexico

Recent and upcoming investment in Mexico

Information collected from media reports over the past month:

  • Motorcycles: Italian vehicle maker Piaggio plans to introduce its Vespa brand of scooters in the Mexican market. The company will invest US$3 million to open seven Vespa agencies in the coming months in conjunction with Mexican distributor Grupo Zapata, the latter company reported. (El Financiero, November 30, 2016)
  • Retail: Mexican developers Thor Urbana and Grupo Orlegi announced plans to build a major shopping center complex in the northern state of Coahuila. The US$90 million site will be constructed as an adjunct to the soccer stadium home to the popular Santos Laguna club of the Mexican soccer league. (El Financiero, November 30, 2016)
  • Hotels: Mexican hotel operator Grupo Posadas inaugurated three new hotels in the northeastern city of Monterrey at a cost of approximately US$60 million, the company reported. The new properties are designed with aspects specifically targeting the millennial market, according to Posadas. (El Financiero, November 25, 2016)
  • Wind power: Unnamed investors will finance the construction of a 40MW wind energy generation plant in the central state of Querétaro, the state government announced. The US$40 million project is planned to include 40 generation turbines. (El Financiero, November 25, 2016)
  • Construction materials: Mexican flooring manufacturer Interceramic initiated construction on a new production plant in the central state of Guanajuato. The US$80 million factory will become the company’s 10th in Mexico. (Obras Web, November 25, 2016)
  • Biofuel: Mexican engineering firm Soluciones en Ingeniería Naval Marina y Terrestre has obtained a permit to construct a biofuel refinery in the eastern state of Veracruz, the Ministry of Environment and Natural Resources (Semarnat) reported. The cost was not specified for the new facility, which is planned to produce 120 million liters annually of ETI01 ethanol. (El Financiero, November 25, 2016) Continue reading Recent and upcoming investment in Mexico

Mexico seeks entry into pharma practices agreement

PharmaMexico’s pharmaceutical industry has been performing well in recent years.  Both multinational subsidiaries and domestic manufacturers are targeting booming maladies like obesity and diabetes, and taking advantage of the relatively low cost of clinical testing and R&D.  But as private sector manufacturers make headlines investing in flashy new laboratories, The Mexican government has been quietly pursuing a regulatory initiative that may soon make an important impact on pharmaceutical manufacturing in the country. Continue reading Mexico seeks entry into pharma practices agreement